Roche Holding AG said it plans to keep studying an experimental compound for its muscle-growth potential during weight loss even as the company halts work on it in neuromuscular disorders because of a lack of effectiveness. <\/p>\n
The scientific rationale for studying the compound, emugrobart, in obesity remains strong, Roche said in an e-mailed statement on Friday. The Swiss drugmaker on Thursday notified patients with spinal muscular atrophy<\/a> and people with facioscapulohumeral muscular dystrophy<\/a> that it was halting work with the compound in both those diseases. <\/p>\n","protected":false},"excerpt":{"rendered":"Roche Holding AG said it plans to keep studying an experimental compound for its muscle-growth potential during weight…\n","protected":false},"author":2,"featured_media":49863,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[22207,13224,28558,4128,23121,10622,28559,8642,304,134,2843,74],"class_list":["post-49862","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-americas","tag-eli-lilly-co","tag-fshd-society","tag-healthcare","tag-industrials","tag-industries","tag-lucienne-ronco","tag-materials","tag-pharmaceutical","tag-roche","tag-science","tag-united-states"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116414011385042460","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/49862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=49862"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/49862\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/49863"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=49862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=49862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=49862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}